YY1 and melanoma: YY1 has been shown to positively regulate immune checkpoint receptors such as PD1 and CTLA-4 (61), and YY1 was upregulated in PD1-positive T cells infiltrating lymphocytes in melanoma tumors and directly regulated the expression of PD1 and LAG3 by binding to the promoter region (62, 63).